BDSI remains committed to the chronic pain community during the COVID-19 pandemic. For more
information on access to our products, please call our customer service line at 1-800-469-0261.

Contact

Corporate Headquarters

4131 Parklake Avenue, Suite 225 Raleigh, NC 27612

Tel: 919-582-9050 Toll-free: 1-877-579-4578 Fax: 919-582-9051

Asterisks denote required fields

Recent BDSI News

February 17, 2021

RALEIGH, N.C. , Feb. 17, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that it will report its fourth quarter and full

Read more
February 11, 2021

Brings Track Record of Success to Expanded Role RALEIGH, N.C. , Feb. 11, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International , Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with chronic conditions, promoted its Chief Financial Officer,

Read more
January 15, 2021

Oral Presentation of Data from Phase I Safety Study & Secondary Respiratory Outcomes Comparing BELBUCA ® to Oxycodone on January 16 from 1:10pm – 2:10pm CT RALEIGH, N.C. , Jan. 15, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International , Inc. (NASDAQ: BDSI), a rapidly growing specialty

Read more
More news

Upcoming Events

BDSI Fourth Quarter 2020 Financial Results Call and Webcast March 10, 2021 8:30 AM EST

Stay Connected

Stay up to date on the latest news

Get started now
February 26, 2021BDSI $4.2/ - -4.76%
Data provided by Nasdaq. Minimum 15 minutes delayed.